Sonnet BioTherapeutics (SONN) Institutional Ownership $1.26 +0.03 (+2.44%) Closing price 04/17/2025 03:59 PM EasternExtended Trading$1.28 +0.02 (+1.59%) As of 04/17/2025 06:24 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Sonnet BioTherapeutics (NASDAQ:SONN)CurrentInstitutional OwnershipPercentage9.45%Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$340.92KNumber ofInstitutional Sellers(last 12 months)0 Get SONN Insider Trade Alerts Want to know when executives and insiders are buying or selling Sonnet BioTherapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data SONN Institutional Buying and Selling by Quarter Sonnet BioTherapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/17/2025Two Sigma Investments LP19,203$28K0.0%N/A0.630% 2/11/2025Virtu Financial LLC39,647$58K0.0%N/A1.300% 8/15/2024Armistice Capital LLC272,000$255K0.0%N/A8.740% 7/27/2023Virtu Financial LLC86,624$42K0.0%N/A0.315% 5/19/2023Anson Funds Management LP1,760,000$634K0.1%N/A6.405% 11/7/2022Virtu Financial LLC26,914$40K0.0%N/A0.622% 8/2/2022Advisory Services Network LLC130,525$37K0.0%+158.3%0.215% 5/10/2022Campion Asset Management90,612$34K0.0%N/A0.150% 8/16/2021State Street Corp62,688$99K0.0%N/A0.253% 8/13/2021Vanguard Group Inc.701,634$1.11M0.0%+416.0%2.834% 5/19/2021Virtu Financial LLC65,106$146K0.0%N/A0.371% 5/18/2021Citadel Advisors LLC113,264$255K0.0%N/A0.534% 5/18/2021Jane Street Group LLC17,304$39K0.0%N/A0.099% 5/17/2021Price T Rowe Associates Inc. MD45,100$101K0.0%N/A0.257% 5/13/2021Bank of New York Mellon Corp20,399$46K0.0%N/A0.116% 5/7/2021BlackRock Inc.255,761$575K0.0%+3.7%1.457% 3/26/2021Susquehanna International Group LLP15,434$34K0.0%N/A0.088% (Data available from 1/1/2016 forward) SONN Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of SONN shares? During the previous two years, the following institutional investors and hedge funds held shares of Sonnet BioTherapeutics shares: Anson Funds Management LP ($634K), Armistice Capital LLC ($255K), and Virtu Financial LLC ($58K), Two Sigma Investments LP ($28K).Learn more on SONN's institutional investors. What percentage of Sonnet BioTherapeutics stock is owned by institutional investors? 9.45% of Sonnet BioTherapeutics stock is owned by institutional investors. Learn more on SONN's institutional investor holdings. Which institutional investors have been buying Sonnet BioTherapeutics stock? The following institutional investors have purchased Sonnet BioTherapeutics stock in the last 24 months: Anson Funds Management LP ($1.76M), Armistice Capital LLC ($272K), Virtu Financial LLC ($126.27K), and Two Sigma Investments LP ($19.20K). How much institutional buying is happening at Sonnet BioTherapeutics? Institutional investors have bought a total of 2,177,474 shares in the last 24 months. This purchase volume represents approximately $15.21M in transactions. Related Companies Chemomab Therapeutics Institutional Ownership Elevation Oncology Institutional Ownership BriaCell Therapeutics Institutional Ownership Bullfrog AI Institutional Ownership Cingulate Institutional Ownership BioAtla Institutional Ownership MIRA Pharmaceuticals Institutional Ownership 23andMe Institutional Ownership NeuroSense Therapeutics Institutional Ownership Calidi Biotherapeutics Institutional Ownership This page (NASDAQ:SONN) was last updated on 4/20/2025 by MarketBeat.com Staff From Our PartnersThe real reason gold is soaring (and likely to continue)Trump’s Policies Are Fueling a Gold Boom—Here’s Your Chance to Profit Donald Trump’s bold policies are driv...Golden Portfolio | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThe first casualty of the 2025 trade warThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredRead before the next tariff announcementLarry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sonnet BioTherapeutics Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sonnet BioTherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.